The hemagglutination inhibition test (HAI) and the enzyme-linked immunosorbent assay (ELISA) for detecting antibody to rubella virus were compared by testing 25 sets of paired sera taken before and after infection and 10 sets of sera taken during acute and convalescent stages of the disease and by screening 700 serum samples from the Collaborative Perinatal Project, NIH/NINCDS. The tests were found to be comparable in their ability to detect positive and negative sera, rises in titers, and seroconversions. When a purified antigen and carefully prepared reagents were used, ELISA was found to be as accurate and reliable as HAI. ELISA required no pretreatment of serum, could easily be automated, and was less time-consuming than HAI.
Widespread rubella vaccination in the United
States has reduced the incidence of rubella infection considerably, but small outbreaks continue to occur. For children and adults the disease is relatively benign, but for the developing fetus carried by an infected woman the results can be serious. The accurate determination of antibody levels to rubella virus, therefore, is of importance not only in screening for immune status, but also in confirming recent infections.
The hemagglutination inhibition test (HAI) is currently the most commonly used technique for determination of rubella antibody titer. This test is time-and labor-consuming. Satisfactory performance requires careful absorption of nonspecific inhibitors, and the method is not easily automated. Reports from the Centers for Disease Control indicate that there is considerable laboratory to laboratory variation, both in the detection of antibody and in the determination of titer by HAI (13) (14) (15) . The enzyme-linked immunosorbent assay (ELISA), which has been shown to offer good sensitivity, ease and speed of performance, and adaptability to semiautomation, has been suggested as an alternative method for rubella serology. We report in this paper a comparison of HAI and ELISA using sera from a large perinatal study.
MATERIALS AND METHODS Specimens. Sera for these tests were selected from a long-range study of over 6,000 women who were pregnant during the 1964 epidemic of rubella in the United States and were included in the Collaborative Perinatal Project, NIH/NINCDS. Studies of these women and their children have been reported previously (12) . The sera were stored at -20°C before use. Test sera included samples from 25 patients before and after natural rubella infection during pregnancy and from 10 patients during the acute and convalescent stages of rubella infection. Randomly selected sera from 500 pregnant women were used for overall comparison, and 200 samples selected because of negative or low HAI rubella titers were also tested.
HAI. The HAI procedure has been described in detail previously (9, 11) . Briefly, the test used kaolin absorption of the sera, newborn chick erythrocytes, and Flow HAI (Flow Laboratories, McLean, Va.) antigen (Gilchrist strain in Vero cells) in microtiter plates. The starting serum dilution was 1:4. The samples used had previously been tested by HAI, but all were retested for this study.
ELISA. (i) Antigen. HPV-77 rubella virus grown in Vero cells was purified on a sucrose gradient by Preston Dorsett. The method of purification and concentration has been previously described (4) . The optimum working dilution, 1:200, was determined by block titration, using known positive and negative sera and a pretested conjugate. The dilution chosen corresponded to approximately four antigenic units on the basis of endpoint titration of known positive serum in cuvettes sensitized with serial twofold dilutions of antigen. Antigens were stored at -70°C for up to 6 months before use with no loss in activity.
(ii) Conjugates. Commercially available (Cappell Laboratories, Cochranville, Pa.) goat anti-human immunoglobulin G (heavy and light chain) was purified and conjugated to alkaline phosphatase by a method previously described (6) .
(iii) Assay. Performance of the test and quantitation of the results has been described elsewhere (6 Positive and negative standard sera were included with the test samples. Each day a standard reference curve was prepared by plotting absorbance readings of serial half-log dilutions of positive and negative standard sera (Fig. 1 ). This curve was used to determine the relative antibody activity of the test samples. The linear part of the S-shaped curve thus obtained represented the optically effective absorbance range. Test samples gave a similar and parallel curve. The difference in logs between the two curves in the optically A standard curve was obtained byplotting the optical density readings of a serial 0.5-log dilution ofknown positive serum. Samples were tested at dilutions of 1/50, 1/ 500, and 1/5,000 corresponding to log -1.7, -2.7, and -3.7, respectively. The difference in logs between a sample and the standard is the ED. In these tests the difference in logs between the curve of the positive standard and the negative standard was found to be -2. effective absorbance range was the ED. Samples with lower activity than the reference serum had a negative ED; those with higher activity had a positive ED. To simplify the expression, an arbitrary zero titer of log -2.8, corresponding to the average ED value of the known negative serum, was used. Positive ED values were then derived by subtracting this value from all EDs determined from the curve. A programmable Hewlett-Packard 9815A calculator was interfaced with the ELISA reader and automatically made these determinations, giving both optical density and ED readings.
Three dilutions of each test sample were run because sera with very low or high antibody levels frequently gave absorbance readings which were outside of the linear part of the reference curve at one or two of the dilutions.
Sucrose gradient density centrifugation. Sixteen low-antibody-level samples giving divergent results by the two tests were retested after centrifugation on a sucrose gradient.
The serum fractionation procedure on a sucrose gradient as outlined in the Center for Disease Control procedural guide was used (8) . A total of 0.5 ml of serum was layered on a 10 to 50% sucrose gradient (pH 7.2) and centrifuged at 32,000 rpm for 18 h in a Spinco ultracentrifuge rotor (SW50.1). Ten 0.5-ml fractions were collected from the bottom of the tube and tested by single radial diffusion to determine those fractions containing immunoglobulin G and M components. HAI and ELISA determinations were repeated after the inmmunoglobulin fractions were pooled, concentrated to the original volume, and dialyzed against phosphate-buffered saline to remove the sucrose.
RESULTS
Results of HAI and ELISA for 25 paired sera obtained before and after known rubella infections are presented in Table 1 . Ail preinfection sera were negative by HAI, whereas 9 of 25 samples gave minimal ELISA readings ranging from ED 0.3 to ED 0.6. Postinfection sera all gave strongly positive readings by both tests. Significant seroconversions were observed with all paired sera by both HAI and ELISA. The low-level ELISA readings with the preinfection sera indicated that an ED of 0.6 was not protective and probably did not indicate the presence of true antibody. To avoid these "false positive" readings, we selected an ED twice that obtained with any of the known preinfection sera and used this as the threshold value for protective antibody (ED 1.2).
In Table 2 the results of HAI and ELISA with sera obtained from 10 patients during the acute and convalescent phases of rubella infections are presented. The first sample was taken while the rash was apparent, and the second was taken 16 close agreement in the identification of positive and negative sera with the tw tests. The distria significant change in antibody level. All paired bution of results with low-level titers suggested sera showed significant increases in antibody by that the greater sensitivity of ELISA might asboth HAI (-4-fold increase in titer) and ELISA sist in the problem of detecting low rubella an-(-0.2 increase in ED value).
tibody levels. Samples from the perinatal study Comparisons of HAI titers with ELISA ED of 200 sera which had low or negative rubella values for sera from 500 randomly selected preg-HAI titers were selected and tested by HAI and nant women are presented in Fig. 2 Fig. 3 . Again, there was close agreement on the determination of positive or negative sera.
Of the 700 sera tested, 183 had an HAI titer of c4. Of these, 80 gave ED readings ranging from 0.2 to 1.6. Sixteen samples from the 80 were subjected to centrifugation on a sucrose gradient. After retesting there was very little change in either HAI titer or ELISA ED value.
The data indicated that the threshold ED of 1.2 was quite comparable to an HAI titer of 8, the level which is generally accepted, on the basis of clinical evidence, as the lower limit of antibody which will render an individual immune. Using these thresholds (HAI 5 8 and ED > 1.2), the sensitivity and specificity of ELISA relative to HAI could be determined. Of the total 700 sera in the two groups, 517 were positive by HAI. Of these 517, 514 In general, serum specimens with higher HAI titers had higher ED values. There was, however, considerable overlap and no clear correlation could be made between individual ED values and HAI serum titers, probably because the two tests are not dependent upon exactly the same antibody attachments. If more specific titer information is required, ELISA endpoint determinations on serial serum dilutions may be of more value.
Although the rubella ELISA has been described in the literature many times (2-5, 7, 15) , no standardized method has yet emerged. Standard high-positive, low-positive, and negative sera should be included as controls in any test. Use of national or international reference standards in all variations of the test would permit more meaningful evaluation and reporting of results.
In our laboratory, the ELISA, performed by experienced technicians with highly purified antigen and carefully prepared reagents, gave satisfactory results and was particularly well adapted to screening large numbers of sera. No pretreatment of serum is necessary and the test is rapid, sensitive, and specific. The system can be adapted to endpoint titrations and can be easily automated and adapted to a wide variety of antigens. With increasing availability of reliable reagents and reading equipment, ELISA could be the method of choice for many laboratories.
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